Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE‐CARE multicentre randomized controlled trial

Boriani, Giuseppe; Costa, Antoine Da; Quesada, Aurelio; Ricci, Renato Pietro; Favale, Stefano; Boscolo, Gabriele; Clémenty, Nicolas; Amori, Valentina; Stefano, Lorenza Mangoni di S.; Burri, Haran

doi:10.1002/ejhf.626

Cited by 173 publications

(169 citation statements)

References 32 publications

Supporting

Mentioning

153

Contrasting

Unclassified

Order By: Relevance

“…Since remote monitoring is essentially a diagnostic adjunct rather than an intervention, this may explain the lack of effect on patient outcome 67 . Similar results were obtained in two other recent studies 68 , 69 …”

Section: Telemedicine In the Management Of Heart Failure Patients To supporting

confidence: 93%

The future of telemedicine for the management of heart failure patients: a Consensus Document of the Italian Association of Hospital Cardiologists (A.N.M.C.O), the Italian Society of Cardiology (S.I.C.) and the Italian Society for Telemedicine and eHealth (Digital S.I.T.)

Lenarda

Casolo

Gulizia

et al. 2017

European Heart Journal Supplements

Self Cite

View full text Add to dashboard Cite

Telemedicine applied to heart failure patients is a tool for recording and providing remote transmission, storage and interpretation of cardiovascular parameters and/or useful diagnostic images to allow for intensive home monitoring of patients with advanced heart failure, or during the vulnerable post-acute phase, to improve patient’s prognosis and quality of life.Recently, several meta-analyses have shown that telemedicine-supported care pathways are not only effective but also economically advantageous. Benefits seem to be substantial, with a 30–35% reduction in mortality and 15–20% decrease in hospitalizations. Patients implanted with cardiac devices can also benefit from an integrated remote clinical management since all modern devices can transmit technical and diagnostic data. However, telemedicine may provide benefits to heart failure patients only as part of a shared and integrated multi-disciplinary and multi-professional ‘chronic care model’. Moreover, the future development of remote telemonitoring programs in Italy will require the primary use of products certified as medical devices, validated organizational solutions as well as legislative and administrative adoption of new care methods and the widespread growth of clinical care competence to remotely manage the complexity of chronicity.Through this consensus document, Italian Cardiology reaffirms its willingness to contribute promoting a new phase of qualitative assessment, standardization of processes and testing of telemedicine-based care models in heart failure.By recognizing the relevance of telemedicine for the care of non-hospitalized patients with heart failure, its strategic importance for the design of innovative models of care, and the many challenges and opportunities it raises, ANMCO and SIC through this document report a consensus on the main directions for its widespread and sustainable clinical implementation

show abstract

Section: Telemedicine In the Management Of Heart Failure Patients To supporting

confidence: 93%

The future of telemedicine for the management of heart failure patients: a Consensus Document of the Italian Association of Hospital Cardiologists (A.N.M.C.O), the Italian Society of Cardiology (S.I.C.) and the Italian Society for Telemedicine and eHealth (Digital S.I.T.)

Lenarda

Casolo

Gulizia

et al. 2017

European Heart Journal Supplements

Self Cite

View full text Add to dashboard Cite

show abstract

“…A recent meta-analysis [14] reported higher costs of standard follow-up as compared with RM mostly due a reduction in planned visits. Similar results have been observed in the MORE-CARE study [22], in which the composite endpoint of healthcare resource utilization (i.e. 2-year rates of CV hospitalizations, CV emergency department admissions, and CV in-office follow-ups), had a significant 38% reduction in the RM versus the standard arm (incidence rate ratio 0.62, 95% CI 0.58-0.66, p < 0.001) mainly driven by a reduction in in-office visits.…”

Section: Cost-effectivenesssupporting

confidence: 77%

“…The trial was terminated prematurely because of lower than expected enrollment (which predicted remarkable underpowering of the study). The analysis set included data from the 2-year follow-up [22]. …”

Section: Advances In Understanding the Effectiveness Of Rm From Recenmentioning

confidence: 99%

Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure

2016

View full text Add to dashboard Cite

“…7 In all, 917 HF patients with CRT-D devices were randomized to remote and in-office device checks or the standard arm with all checks performed in the office. At a median follow-up period of 24 months, no difference between the study arms was found for the primary endpoint including all-cause death, CVD or devicerelated hospitalizations (29.7% vs. 28.7% HR 1.02, 95% CI 0.80-1.30, P=0.889) or its components.…”

Section: Andreas Gruntzig's Lecturementioning

confidence: 99%

European Society of Cardiology (ESC) Annual Congress Report From Rome 2016

Mizuno

Otani

Sakata

2016

Circ J

View full text Add to dashboard Cite

From August 27th to 31st, the 2016 Annual Congress of the European Society of Cardiology (ESC 2016) was held in Fiera di Roma, Italy. Despite the socially unstable situation, more than 32,000 attendees, including clinical physicians, basic researchers, medical students, and paramedical personnel, as well as 5,000 exhibitors from 106 countries gathered in this historical city to share the latest findings and to discuss the present issues in cardiovascular medicine. There were scientific sessions, including 28 Hot Lines, 26 clinical trial updates, 24 registry studies, and 5 clinical practice guideline sessions. Japan had 1,170 attendees, with 1,743 submitted and 670 accepted abstracts, including the NIPPON trial presented in the hotline session. From 2011 to 2016, Japan has been the first abstract submitter and has had the most abstracts accepted, which indicates the great contribution of Japanese cardiologists and the Japanese Circulation Society. This report briefly introduces the key presentations and highlights from the ESC 2016 Scientific Sessions. (Circ J 2016; 80: 2282 -2286

show abstract

Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE‐CARE multicentre randomized controlled trial

Abstract: NCT00885677.

Cited by 173 publications

References 32 publications

The future of telemedicine for the management of heart failure patients: a Consensus Document of the Italian Association of Hospital Cardiologists (A.N.M.C.O), the Italian Society of Cardiology (S.I.C.) and the Italian Society for Telemedicine and eHealth (Digital S.I.T.)

The future of telemedicine for the management of heart failure patients: a Consensus Document of the Italian Association of Hospital Cardiologists (A.N.M.C.O), the Italian Society of Cardiology (S.I.C.) and the Italian Society for Telemedicine and eHealth (Digital S.I.T.)

Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure

European Society of Cardiology (ESC) Annual Congress Report From Rome 2016

Contact Info

Product

Resources

About